Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
American Journal of Mental Retardation : AJMR|January 1, 1995
Blink rate as an index of dopamine function in adults with mental retardation and repetitive behavior disordersJ W Bodfish, S B Powell, R N Golden, et al.
American Journal of Mental Retardation : AJMR|November 1, 1995
Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardationM H Lewis, J W Bodfish, S B Powell, et al.
Experimental and Clinical Psychopharmacology|September 6, 2001
The changing effector pattern of tardive dyskinesia during the course of neuroleptic withdrawalK M Newell, B Wszola, R L Sprague, et al.
American Journal of Mental Retardation : AJMR|July 1, 1996
Self-restraint and self-injury: occurrence and motivational significanceS B Powell, J W Bodfish, D Parker, et al.
American Journal of Mental Retardation : AJMR|May 1, 1996
Clomipramine treatment for self-injurious behavior of individuals with mental retardation: a double-blind comparison with placeboM H Lewis, J W Bodfish, S B Powell, et al.
American Journal of Mental Retardation : AJMR|January 1, 1997
Akathisia in adults with mental retardation: development of the Akathisia Ratings of Movement Scale (ARMS)J W Bodfish, K M Newell, R L Sprague, et al.
American Journal of Mental Retardation : AJMR|September 1, 1996
Dyskinetic movement disorder among adults with mental retardation: phenomenology and co-occurrence with stereotypyJ W Bodfish, K M Newell, R L Sprague, et al.
American Journal of Mental Retardation : AJMR|April 26, 2001
Stereotypy and motor control: differences in the postural stability dynamics of persons with stereotyped and dyskinetic movement disordersJ W Bodfish, D E Parker, M H Lewis, et al.
Experimental and Clinical Psychopharmacology|September 6, 2001
Sequential analysis of the effects of naltrexone on the environmental mediation of self-injurious behaviorF J Symons, J Tapp, A Wulfsberg, et al.
The New England Journal of Medicine|December 10, 1999
Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorderA D Sandler, K A Sutton, J DeWeese, et al.
Pageof 3